Weight & Metabolic Health · Dual GIP/GLP-1 agonist
Tirzepatide
10 mg · lyophilized vialWeekly subcutaneous injectionEstablished
A dual-agonist alternative your provider may consider based on your history, response and tolerability — never on request.
01Considered where GLP-1 response or tolerability falls short
02Same monthly review and titration discipline as GLP-1 Care
03Protein and strength targets run alongside the medication
04Switching agents is a provider decision with a plan attached
Prescription only. This vial is dispensed within a programme after a provider reviews your intake — it is not sold on its own, and enrolling does not guarantee it will be prescribed.
Also in Weight & Metabolic Health
Full formularyA provider decides — start there.
Pick your state and we'll tell you straight away whether the relevant programme is available.
This formulary is illustrative. Names, strengths, forms and pricing are placeholders pending clinical, pharmacy and legal sign-off. Nothing here is sold on its own: medication is dispensed by a licensed pharmacy inside a programme, only after a provider decides it belongs in your plan — and no is a real answer.